Added to YB: 2026-06-25
Pitch date: 2026-06-23
ALAFY.PA [neutral]
AFYREN SAS
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids.
Market Cap
EUR 102.1M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.47
P/E
-5.35
EV/Sales
30.44
Sector
Chemicals
Category
growth
Afyren (ALAFY France): The technology story is becoming an industrial story
ALAFY.PA (update): Bio-based acids maker transitioning from tech story to industrial scaling. NEOXY plant at ~20% of 16,000-ton nameplate, several hundred tons delivered H1 2026, rev already topping all of 2025. €165m secured contracts, ~15 customers, all output sold. Kemin Industries now shareholder. Acquired remaining 49% of NEOXY, simplifying economics but adding project debt to group. Targeting breakeven ~2028, full utilization 2028, possible 2nd plant ~2030. Ramp pace & financing are key risks.
Read full article (2 min)